EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitLeitlinieOpen Access · CC BY 4.0

Spotlight on the 2024 ESC/EACTS management of atrial fibrillation guidelines: 10 novel key aspects

Michiel Rienstra iD, Stylianos Tzeis iD, Karina V Bunting iD, Valeria Caso iD, Harry J G M Crijns iD, Tom J R De Potter iD, Prashanthan Sanders iD, Emma Svennberg iD, Ruben Casado-Arroyo iD, Jeremy Dwight, Luigina Guasti iD, Thorsten Hanke iD und 14 weitere

Europace · 03.12.2024 · 26 (12)

DOI: 10.1093/europace/euae298 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Europace, online erschienen am 24.12.2024. Verfasst von Michiel Rienstra und 25 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, University of Groningen, University Medical Center Groningen, P.O. Box 30.001, 9700 RB Groningen, The Netherlands. Hauptthemen laut MEDLINE: Atrial Fibrillation, Practice Guidelines as Topic, Anticoagulants, Catheter Ablation. Die Arbeit wurde bisher 145-mal zitiert (Crossref) und nennt 140 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bayer, InCarda Therapeutics, Dutch Cardiovascular Alliance.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Atrial fibrillation (AF) remains the most common cardiac arrhythmia worldwide and is associated with significant morbidity and mortality. The European Society of Cardiology (ESC)/European Association for Cardio-Thoracic Surgery (EACTS) have recently released the 2024 guidelines for the management of AF. This review highlights 10 novel aspects of the ESC/EACTS 2024 Guidelines. The AF-CARE framework is introduced, a structural approach that aims to improve patient care and outcomes, comprising of four pillars: [C] Comorbidity and risk factor management, [A] Avoid stroke and thromboembolism, [R] Reduce symptoms by rate and rhythm control, and [E] Evaluation and dynamic reassessment. Additionally, graphical patient pathways are provided to enhance clinical application. A significant shift is the new emphasis on comorbidity and risk factor control to reduce AF recurrence and progression. Individualized assessment of risk is suggested to guide the initiation of oral anticoagulation to prevent thromboembolism. New guidance is provided for anticoagulation in patients with trigger-induced and device-detected sub-clinical AF, ischaemic stroke despite anticoagulation, and the indications for percutaneous/surgical left atrial appendage exclusion. AF ablation is a first-line rhythm control option for suitable patients with paroxysmal AF, and in specific patients, rhythm control can improve prognosis. The AF duration threshold for early cardioversion was reduced from 48 to 24 h, and a wait-and-see approach for spontaneous conversion is advised to promote patient safety. Lastly, strong emphasis is given to optimize the implementation of AF guidelines in daily practice using a patient-centred, multidisciplinary and shared-care approach, with the simultaneous launch of a patient version of the guideline.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationPractice Guidelines as TopicAnticoagulantsCatheter AblationHumansRisk FactorsThromboembolismRisk AssessmentCardiologyAnti-Arrhythmia AgentsComorbidityStrokeTreatment OutcomeEurope

Stichwörter der Autor:innen

Atrial fibrillationGuidelinesManagement

Substanzen

AnticoagulantsAnti-Arrhythmia Agents

Autor:innen und Institutionen

  • Department of Cardiology, University of Groningen, University Medical Center Groningen, P.O. Box 30.001, 9700 RB Groningen, The Netherlands.
  • Department of Cardiology, Mitera Hospital, Athens, Greece.
  • Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, UK.
  • Stroke Unit, Santa Maria della Misericordia-University of Perugia, Perugia, Italy.
  • Department of Cardiology, Maastricht University Medical Center, Maastricht, The Netherlands.
  • Department of Cardiology, Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, The Netherlands.

ORCID-Profile: Michiel Rienstra, Stylianos Tzeis, Karina V Bunting, Valeria Caso, Harry J G M Crijns, Tom J R De Potter, Prashanthan Sanders, Emma Svennberg, Ruben Casado-Arroyo, Luigina Guasti, Thorsten Hanke, Tiny Jaarsma, Maddalena Lettino, Maja-Lisa Løchen, R Thomas Lumbers, Bart Maesen, Giuseppe M C Rosano, Renate B Schnabel, Piotr Suwalski, Juan Tamargo, Otilia Tica, Vassil Traykov, Dipak Kotecha, Isabelle C Van Gelder

Förderung

  • Bayer
  • InCarda Therapeutics
  • Dutch Cardiovascular Alliance
  • ZonMw
  • Dutch Heart Foundation
  • Netherlands Cardiovascular Research Initiative
  • Horizon 2020
  • Pfizer

Zitieren

APA

Rienstra, M., Tzeis, S., Bunting, K. V., Caso, V., Crijns, H. J. G. M., De Potter, T. J. R., Sanders, P., Svennberg, E., Casado-Arroyo, R., Dwight, J., Guasti, L., Hanke, T., Jaarsma, T., Lettino, M., Løchen, M. L., Lumbers, R. T., Maesen, B., Mølgaard, I., Rosano, G. M. C., …, & Van Gelder, I. C. (2024). Spotlight on the 2024 ESC/EACTS management of atrial fibrillation guidelines: 10 novel key aspects. Europace, 26(12). https://doi.org/10.1093/europace/euae298

Vancouver

Rienstra M, Tzeis S, Bunting KV, Caso V, Crijns HJGM, De Potter TJR, et al. Spotlight on the 2024 ESC/EACTS management of atrial fibrillation guidelines: 10 novel key aspects. Europace. 2024;26(12). doi:10.1093/europace/euae298

BibTeX
@article{Rienstra2024,
  author = {Rienstra, Michiel and Tzeis, Stylianos and Bunting, Karina V and Caso, Valeria and Crijns, Harry J G M and De Potter, Tom J R and Sanders, Prashanthan and Svennberg, Emma and Casado-Arroyo, Ruben and Dwight, Jeremy and Guasti, Luigina and Hanke, Thorsten and Jaarsma, Tiny and Lettino, Maddalena and Løchen, Maja-Lisa and Lumbers, R Thomas and Maesen, Bart and Mølgaard, Inge and Rosano, Giuseppe M C and Schnabel, Renate B and Suwalski, Piotr and Tamargo, Juan and Tica, Otilia and Traykov, Vassil and Kotecha, Dipak and Van Gelder, Isabelle C},
  title = {Spotlight on the 2024 ESC/EACTS management of atrial fibrillation guidelines: 10 novel key aspects},
  journal = {Europace},
  year = {2024},
  volume = {26},
  number = {12},
  doi = {10.1093/europace/euae298}
}
Kostenlos starten →